Ibandronate

Drug Levels and Effects:




Summary of Use during Lactation:


IBecause no information is available on the use of ibandronate during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. However, absorption of ibandronate by a breastfed infant is unlikely.


Drug Levels:


Ibandronate is poorly absorbed orally (average in adults 6% on an empty stomach, negligible with food), so absorption of ibandronate by a breastfed infant is unlikely.

Maternal Levels.

Relevant published information was not found as of the revision date.

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Relevant published information was not found as of the revision date.


Possible Effects on Lactation:


Relevant published information was not found as of the revision date.


Alternate Drugs to Consider:


Pamidronate


References:






Substance Identification:




Substance Name:

Ibandronate

CAS Registry Number:

114084-78-5

Drug Class:


  • Bisphosphonates

  • Bone Density Conservation Agents

  • Diphosphonates


  • Administrative Information:




    LactMed Record Number:


    719


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.